Michael Lim

Egret Therapeutics, Inc. is a clinical-stage biotherapeutics company that aims to become a leading biotechnology company. The company is based in New York, NY. The company focuses on discovering, developing, and commercializing novel therapies that transform treatment paradigms in the management of life-threatening neurological conditions. The company's product development and commercial execution strategies are geared towards achieving this vision. Egret Therapeutics was founded by Daniel Joon-byung Chai, Michael Lim, and Chris Jackson, with Daniel Joon-byung Chai serving as the CEO since incorporation.

Egret Therapeutics, Inc. is a clinical-stage biotherapeutics company that aims to become a leading biotechnology company. The company is based in New York, NY. The company focuses on discovering, developing, and commercializing novel therapies that transform treatment paradigms in the management of life-threatening neurological conditions. The company's product development and commercial execution strategies are geared towards achieving this vision. Egret Therapeutics was founded by Daniel Joon-byung Chai, Michael Lim, and Chris Jackson, with Daniel Joon-byung Chai serving as the CEO since incorporation.